Form 4 for FHTX Foghorn Therapeutics Inc.
Accepted 2024-09-20 00:00:00 ET · period of report 2024-09-18 · accession 0001562180-24-006885 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-09-20 | 2024-09-18 | FHTX | Costa Carlos | CHRO | M - OptEx | $3.72 | +11.6K | 11.6K | New | +$43.1K |
| DT | 2024-09-20 | 2024-09-18 | FHTX | Costa Carlos | CHRO | S - Sale+OE | $10.05 | -11.6K | 0 | -100% | -$116.3K |
| DT | 2024-09-20 | 2024-09-18 | FHTX | Costa Carlos | CHRO | M - OptEx | $0.00 | -11.6K | 76.4K | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-18 | M | A | 11,574 | $3.72 | 11,574 | D | — | — | |
| 2 | Common | Common Stock | 2024-09-18 | S | D | 11,574 | $10.05 | 0 | D | — | — | (F2) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $10.00 to $10.25 per share. |
| 3 | Derivative | Stock Option (right to buy) | 2024-09-18 | M | D | 11,574 | $0.00 | 76,402 | D | $3.72 · — to 2029-02-12 | 11,574 Common Stock | (F3) The option vested as to 25% of the underlying shares of common stock on August 29, 2019, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option was fully vested. |